Literature DB >> 34972715

Amino Acids May Have Protective Effects on Salivary Glands of 5-FU-administered Mice.

Rieko Fujiwara1, Koji Harada2, Tarannum Ferdous1, Katsuaki Mishima1.   

Abstract

BACKGROUND/AIM: This study aimed to identify the most useful components of Elental® in the treatment of 5-fluorouracil (FU)-induced mucositis and salivary gland atrophy in mice.
MATERIALS AND METHODS: Mice (except the control group) were intraperitoneally injected with 5-FU. The mice received saline (control group and 5-FU group), dextrin (Dextrin group), amino acids (17AA group), or Elental® (Elental® group).
RESULTS: The volume and weight of salivary glands was higher in 17AA and Elental® groups compared to 5-FU group. The number of mucous glands was higher, whereas the number of damaged granular ductal epithelial cells was lower in the salivary glands of all groups except the 5-FU group. Salivation was also decreased in the 5-FU group compared to the other groups.
CONCLUSION: Amino acids could be the most effective components of Elental® for protecting mouse salivary glands from 5-FU-induced atrophic changes, and might be useful in the treatment of oral mucositis in cancer patients.
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  5-flurouracil; Salivary gland; amino acid; elemental diet; oral mucositis

Mesh:

Substances:

Year:  2022        PMID: 34972715      PMCID: PMC8765155          DOI: 10.21873/invivo.12691

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  34 in total

1.  Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.

Authors:  D E Peterson; R-J Bensadoun; F Roila
Journal:  Ann Oncol       Date:  2011-09       Impact factor: 32.976

2.  Quantitative determination of immunological components of salivary gland secretion in transplant recipients.

Authors:  F Dens; M Boogaerts; P Boute; D Declerck; H Demuynck; F Vinckier
Journal:  Bone Marrow Transplant       Date:  1996-03       Impact factor: 5.483

3.  Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil.

Authors:  G M McCarthy; J D Awde; H Ghandi; M Vincent; W I Kocha
Journal:  Oral Oncol       Date:  1998-11       Impact factor: 5.337

4.  [Efficacy of Elental on prevention for chemotherapy-induced oral mucositis in colorectal cancer patients].

Authors:  Yutaka Ogata; Masaaki Takeuchi; Nobuya Ishibashi; Shirou Kibe; Kenjirou Takahashi; Shinji Uchida; Naotaka Murakami; Toshirou Yahara; Kazuo Shirouzu
Journal:  Gan To Kagaku Ryoho       Date:  2012-04

5.  Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.

Authors:  T R Ziegler; L S Young; K Benfell; M Scheltinga; K Hortos; R Bye; F D Morrow; D O Jacobs; R J Smith; J H Antin
Journal:  Ann Intern Med       Date:  1992-05-15       Impact factor: 25.391

6.  Updated clinical practice guidelines for the prevention and treatment of mucositis.

Authors:  Dorothy M Keefe; Mark M Schubert; Linda S Elting; Stephen T Sonis; Joel B Epstein; Judith E Raber-Durlacher; Cesar A Migliorati; Deborah B McGuire; Ronald D Hutchins; Douglas E Peterson
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

7.  Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.

Authors:  K M Skubitz; P M Anderson
Journal:  J Lab Clin Med       Date:  1996-02

8.  High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy.

Authors:  R A Brown; R H Herzig; S N Wolff; D Frei-Lahr; L Pineiro; B J Bolwell; J N Lowder; E A Harden; K R Hande; G P Herzig
Journal:  Blood       Date:  1990-08-01       Impact factor: 22.113

Review 9.  The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature.

Authors:  Joel B Epstein; Andrew H F Tsang; Dawn Warkentin; Jonathan A Ship
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2002-07

10.  Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis.

Authors:  Yoichi Saegusa; Takafumi Ichikawa; Tomohisa Iwai; Yukinobu Goso; Tomoaki Ikezawa; Motoko Nakano; Nobuaki Shikama; Katsunori Saigenji; Kazuhiko Ishihara
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

View more
  2 in total

1.  An elemental diet protects mouse salivary glands from 5-fluorouracil-induced atrophy.

Authors:  Koji Harada; Tarannum Ferdous; Rieko Fujiwara; Kenji Watanabe; Yoichi Mizukami; Katsuaki Mishima
Journal:  Oncol Lett       Date:  2022-04-14       Impact factor: 3.111

2.  Xanthine Oxidase Inhibitor, Febuxostat Is Effective against 5-Fluorouracil-Induced Parotid Salivary Gland Injury in Rats Via Inhibition of Oxidative Stress, Inflammation and Targeting TRPC1/CHOP Signalling Pathway.

Authors:  Walaa Yehia Abdelzaher; Mohamed A Nassan; Sabreen Mahmoud Ahmed; Nermeen N Welson; Gaber El-Saber Batiha; Hanaa Mohamed Khalaf
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.